The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo
已获批准的儿科药物苏拉明被确定为治疗EV71感染的临床候选药物——苏拉明在体外和体内均能抑制EV71感染
期刊:Emerging Microbes & Infections
影响因子:8.4
doi:10.1038/emi.2014.60
Peijun Ren, Gang Zou, Benjamin Bailly, Shanshan Xu, Mei Zeng, Xinsheng Chen, Liang Shen, Ying Zhang, Patrice Guillon, Fernando Arenzana-Seisdedos, Philippe Buchy, Jian Li, Mark von Itzstein, Qihan Li, Ralf Altmeyer
